Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China · Delayed Price · Currency is CNY 20.94
-0.18 (-0.85%)
Jul 18, 2025, 2:45 PM CST
SHE:002932 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 38.8 | 74.52 | 74.93 | 4,208 | 1,413 | 468.93 | Upgrade |
Depreciation & Amortization | 62.98 | 62.98 | 83.4 | 59.08 | 23.63 | 17.24 | Upgrade |
Other Amortization | 14.51 | 14.51 | 11.82 | 2.65 | 0.87 | 0.87 | Upgrade |
Loss (Gain) From Sale of Assets | -1.79 | -1.79 | -0.31 | -0.01 | - | -0.15 | Upgrade |
Asset Writedown & Restructuring Costs | 87 | 87 | -4.58 | 646.56 | 21.33 | 6.5 | Upgrade |
Loss (Gain) From Sale of Investments | -135.44 | -135.44 | -125.14 | -37.88 | -0.67 | -1.31 | Upgrade |
Other Operating Activities | -87.78 | -47.28 | 3.29 | 153.33 | 34.62 | 7.33 | Upgrade |
Change in Accounts Receivable | 411.72 | 411.72 | 1,256 | -2,325 | -722.32 | -320.05 | Upgrade |
Change in Inventory | 84.76 | 84.76 | 342.82 | -473.38 | -166.86 | -78.58 | Upgrade |
Change in Accounts Payable | -644.14 | -644.14 | -1,302 | 1,539 | 530.21 | 265.58 | Upgrade |
Change in Other Net Operating Assets | 4.01 | 4.01 | 79.95 | 370.01 | - | - | Upgrade |
Operating Cash Flow | -161.26 | -85.05 | 392.5 | 4,013 | 1,127 | 359.68 | Upgrade |
Operating Cash Flow Growth | - | - | -90.22% | 256.06% | 213.33% | 1499.59% | Upgrade |
Capital Expenditures | -167.84 | -184.77 | -109.97 | -313.38 | -103.57 | -28.28 | Upgrade |
Sale of Property, Plant & Equipment | 0.71 | 0.78 | 0.15 | - | - | 0.01 | Upgrade |
Investment in Securities | -29.46 | 28.04 | -1,290 | -1,958 | -588 | -22.9 | Upgrade |
Other Investing Activities | 19.39 | 17.82 | 34.71 | 37.18 | 6.45 | 7.81 | Upgrade |
Investing Cash Flow | -172.55 | -138.12 | -1,365 | -2,234 | -685.12 | -43.37 | Upgrade |
Short-Term Debt Issued | - | 3 | 23.61 | 137.39 | 30 | 141.5 | Upgrade |
Total Debt Issued | 3 | 3 | 23.61 | 137.39 | 30 | 141.5 | Upgrade |
Short-Term Debt Repaid | - | -23.61 | -125 | -53.42 | -141.5 | - | Upgrade |
Long-Term Debt Repaid | - | -6 | -20.49 | -4.72 | -2.95 | - | Upgrade |
Total Debt Repaid | -15.97 | -29.61 | -145.49 | -58.14 | -144.45 | - | Upgrade |
Net Debt Issued (Repaid) | -12.97 | -26.61 | -121.87 | 79.24 | -114.45 | 141.5 | Upgrade |
Issuance of Common Stock | - | - | - | - | 482.71 | 49.39 | Upgrade |
Repurchase of Common Stock | -238.16 | -238.16 | -0.53 | - | - | - | Upgrade |
Common Dividends Paid | -47.28 | -47.39 | -582.48 | -550.64 | -283.39 | -8.44 | Upgrade |
Other Financing Activities | -15.86 | -1.01 | 34.83 | 38.6 | -2.6 | 0.47 | Upgrade |
Financing Cash Flow | -314.28 | -313.17 | -670.06 | -432.79 | 82.27 | 182.92 | Upgrade |
Foreign Exchange Rate Adjustments | 0.85 | 0.51 | 1.26 | 19.47 | -3.2 | -0.64 | Upgrade |
Net Cash Flow | -647.24 | -535.83 | -1,641 | 1,365 | 520.96 | 498.6 | Upgrade |
Free Cash Flow | -329.1 | -269.81 | 282.52 | 3,699 | 1,023 | 331.4 | Upgrade |
Free Cash Flow Growth | - | - | -92.36% | 261.47% | 208.82% | - | Upgrade |
Free Cash Flow Margin | -91.66% | -77.08% | 37.69% | 35.13% | 36.17% | 34.55% | Upgrade |
Free Cash Flow Per Share | -1.53 | -1.20 | 1.24 | 16.09 | 4.84 | 1.59 | Upgrade |
Cash Interest Paid | 0.03 | - | - | - | - | - | Upgrade |
Cash Income Tax Paid | 2.98 | 4.45 | 268.9 | 1,253 | 219.86 | 87.78 | Upgrade |
Levered Free Cash Flow | -297.08 | -188.62 | 281.92 | 2,660 | 631.65 | 259.58 | Upgrade |
Unlevered Free Cash Flow | -296.62 | -187.81 | 288.49 | 2,662 | 632.97 | 259.99 | Upgrade |
Change in Net Working Capital | 92.27 | -10.9 | -298.24 | 323.83 | 416.54 | 100 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.